Global Platinum-based Anticancer Drugs Market Outlook 2021

Publisher Name :
Date: 30-Dec-2020
No. of pages: 123
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Platinum-based Anticancer Drugs market is segmented into

- Cisplatin

- Carboplatin

- Oxaliplatin

- Nedaplatin

- Others

Segment by Application

- Testicular Cancer

- Osteosarcoma

- Breast Cancer

- Esophageal Cancer

- NSCLC

- Other

Global Platinum-based Anticancer Drugs Market: Regional Analysis

The Platinum-based Anticancer Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Platinum-based Anticancer Drugs market report are:

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Platinum-based Anticancer Drugs Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Platinum-based Anticancer Drugs market include:

- Sanofi-Aventis

- Yakult honsha

- Dr Reddy's laboratories

- Sun Pharmaceutical

- Teva

- Fresenius Kabi

- Hospira(Pfizer)

- Mylan

- Taj Pharmaceuticals

- Jiangsu Hengrui Medicine

- Nanjing Pharmaceutical Factory

- Jiangsu Aosaikang Pharmaceutical

- Qilu Pharmaceutical

- Hisun Pharmaceutical

- Luoxin

- Lingnan Pharmacy

- Hansoh Pharma

Global Platinum-based Anticancer Drugs Market Outlook 2021

Table of Contents
1 Platinum-based Anticancer Drugs Market Overview
1.1 Product Overview and Scope of Platinum-based Anticancer Drugs
1.2 Platinum-based Anticancer Drugs Segment by Type
1.2.1 Global Platinum-based Anticancer Drugs Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Cisplatin
1.2.3 Carboplatin
1.2.4 Oxaliplatin
1.2.5 Nedaplatin
1.2.6 Others
1.3 Platinum-based Anticancer Drugs Segment by Application
1.3.1 Platinum-based Anticancer Drugs Sales Comparison by Application: (2020-2026)
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.3.5 Esophageal Cancer
1.3.6 NSCLC
1.3.7 Other
1.4 Global Platinum-based Anticancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Platinum-based Anticancer Drugs Revenue 2015-2026
1.4.2 Global Platinum-based Anticancer Drugs Sales 2015-2026
1.4.3 Platinum-based Anticancer Drugs Market Size by Region: 2020 Versus 2026
2 Global Platinum-based Anticancer Drugs Market Competition by Manufacturers
2.1 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Platinum-based Anticancer Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Platinum-based Anticancer Drugs Manufacturing Sites, Area Served, Product Type
2.5 Platinum-based Anticancer Drugs Market Competitive Situation and Trends
2.5.1 Platinum-based Anticancer Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Platinum-based Anticancer Drugs Players (Opinion Leaders)
3 Platinum-based Anticancer Drugs Retrospective Market Scenario by Region
3.1 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.3.1 North America Platinum-based Anticancer Drugs Sales by Country
3.3.2 North America Platinum-based Anticancer Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.4.1 Europe Platinum-based Anticancer Drugs Sales by Country
3.4.2 Europe Platinum-based Anticancer Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Platinum-based Anticancer Drugs Sales by Region
3.5.2 Asia Pacific Platinum-based Anticancer Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.6.1 Latin America Platinum-based Anticancer Drugs Sales by Country
3.6.2 Latin America Platinum-based Anticancer Drugs Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country
3.7.2 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Platinum-based Anticancer Drugs Historic Market Analysis by Type
4.1 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2015-2020)
4.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Platinum-based Anticancer Drugs Price Market Share by Type (2015-2020)
4.4 Global Platinum-based Anticancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Platinum-based Anticancer Drugs Historic Market Analysis by Application
5.1 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2015-2020)
5.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Platinum-based Anticancer Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Platinum-based Anticancer Drugs Business
6.1 Sanofi-Aventis
6.1.1 Corporation Information
6.1.2 Sanofi-Aventis Description, Business Overview
6.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi-Aventis Products Offered
6.1.5 Sanofi-Aventis Recent Development
6.2 Yakult honsha
6.2.1 Yakult honsha Corporation Information
6.2.2 Yakult honsha Description, Business Overview
6.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Yakult honsha Products Offered
6.2.5 Yakult honsha Recent Development
6.3 Dr Reddy's laboratories
6.3.1 Dr Reddy's laboratories Corporation Information
6.3.2 Dr Reddy's laboratories Description, Business Overview
6.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Dr Reddy's laboratories Products Offered
6.3.5 Dr Reddy's laboratories Recent Development
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Corporation Information
6.4.2 Sun Pharmaceutical Description, Business Overview
6.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sun Pharmaceutical Products Offered
6.4.5 Sun Pharmaceutical Recent Development
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description, Business Overview
6.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Teva Products Offered
6.5.5 Teva Recent Development
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description, Business Overview
6.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Fresenius Kabi Products Offered
6.6.5 Fresenius Kabi Recent Development
6.7 Hospira(Pfizer)
6.6.1 Hospira(Pfizer) Corporation Information
6.6.2 Hospira(Pfizer) Description, Business Overview
6.6.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hospira(Pfizer) Products Offered
6.7.5 Hospira(Pfizer) Recent Development
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description, Business Overview
6.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Mylan Products Offered
6.8.5 Mylan Recent Development
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description, Business Overview
6.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Taj Pharmaceuticals Products Offered
6.9.5 Taj Pharmaceuticals Recent Development
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Corporation Information
6.10.2 Jiangsu Hengrui Medicine Description, Business Overview
6.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Jiangsu Hengrui Medicine Products Offered
6.10.5 Jiangsu Hengrui Medicine Recent Development
6.11 Nanjing Pharmaceutical Factory
6.11.1 Nanjing Pharmaceutical Factory Corporation Information
6.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Description, Business Overview
6.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Nanjing Pharmaceutical Factory Products Offered
6.11.5 Nanjing Pharmaceutical Factory Recent Development
6.12 Jiangsu Aosaikang Pharmaceutical
6.12.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Description, Business Overview
6.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Jiangsu Aosaikang Pharmaceutical Products Offered
6.12.5 Jiangsu Aosaikang Pharmaceutical Recent Development
6.13 Qilu Pharmaceutical
6.13.1 Qilu Pharmaceutical Corporation Information
6.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Description, Business Overview
6.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Qilu Pharmaceutical Products Offered
6.13.5 Qilu Pharmaceutical Recent Development
6.14 Hisun Pharmaceutical
6.14.1 Hisun Pharmaceutical Corporation Information
6.14.2 Hisun Pharmaceutical Platinum-based Anticancer Drugs Description, Business Overview
6.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Hisun Pharmaceutical Products Offered
6.14.5 Hisun Pharmaceutical Recent Development
6.15 Luoxin
6.15.1 Luoxin Corporation Information
6.15.2 Luoxin Platinum-based Anticancer Drugs Description, Business Overview
6.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Luoxin Products Offered
6.15.5 Luoxin Recent Development
6.16 Lingnan Pharmacy
6.16.1 Lingnan Pharmacy Corporation Information
6.16.2 Lingnan Pharmacy Platinum-based Anticancer Drugs Description, Business Overview
6.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Lingnan Pharmacy Products Offered
6.16.5 Lingnan Pharmacy Recent Development
6.17 Hansoh Pharma
6.17.1 Hansoh Pharma Corporation Information
6.17.2 Hansoh Pharma Platinum-based Anticancer Drugs Description, Business Overview
6.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Hansoh Pharma Products Offered
6.17.5 Hansoh Pharma Recent Development
7 Platinum-based Anticancer Drugs Manufacturing Cost Analysis
7.1 Platinum-based Anticancer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Platinum-based Anticancer Drugs
7.4 Platinum-based Anticancer Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Platinum-based Anticancer Drugs Distributors List
8.3 Platinum-based Anticancer Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Platinum-based Anticancer Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Type (2021-2026)
10.2 Platinum-based Anticancer Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Application (2021-2026)
10.3 Platinum-based Anticancer Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Platinum-based Anticancer Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Platinum-based Anticancer Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Platinum-based Anticancer Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Platinum-based Anticancer Drugs Manufacturers Covered in This Study
Table 5. Global Platinum-based Anticancer Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Platinum-based Anticancer Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Platinum-based Anticancer Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Platinum-based Anticancer Drugs Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Platinum-based Anticancer Drugs Sales Sites and Area Served
Table 11. Manufacturers Platinum-based Anticancer Drugs Product Types
Table 12. Global Platinum-based Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Platinum-based Anticancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum-based Anticancer Drugs as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Platinum-based Anticancer Drugs Players
Table 16. Global Platinum-based Anticancer Drugs Sales (K Units) by Region (2015-2020)
Table 17. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Platinum-based Anticancer Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Platinum-based Anticancer Drugs Sales by Country (2015-2020) (K Units)
Table 21. North America Platinum-based Anticancer Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Platinum-based Anticancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Platinum-based Anticancer Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Platinum-based Anticancer Drugs Sales by Country (2015-2020) (K Units)
Table 25. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Platinum-based Anticancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Platinum-based Anticancer Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Platinum-based Anticancer Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Platinum-based Anticancer Drugs Sales by Country (2015-2020) (K Units)
Table 33. Latin America Platinum-based Anticancer Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Platinum-based Anticancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Platinum-based Anticancer Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Platinum-based Anticancer Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Platinum-based Anticancer Drugs Sales Share by Type (2015-2020)
Table 42. Global Platinum-based Anticancer Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Platinum-based Anticancer Drugs Revenue Share by Type (2015-2020)
Table 44. Global Platinum-based Anticancer Drugs Price (US$/Unit) by Type (2015-2020)
Table 45. Global Platinum-based Anticancer Drugs Sales (K Units) by Application (2015-2020)
Table 46. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Platinum-based Anticancer Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Sanofi-Aventis Corporation Information
Table 49. Sanofi-Aventis Description and Business Overview
Table 50. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Sanofi-Aventis Main Product
Table 52. Sanofi-Aventis Recent Development
Table 53. Yakult honsha Corporation Information
Table 54. Yakult honsha Description and Business Overview
Table 55. Yakult honsha Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Yakult honsha Main Product
Table 57. Yakult honsha Recent Development
Table 58. Dr Reddy's laboratories Corporation Information
Table 59. Dr Reddy's laboratories Description and Business Overview
Table 60. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Dr Reddy's laboratories Main Product
Table 62. Dr Reddy's laboratories Recent Development
Table 63. Sun Pharmaceutical Corporation Information
Table 64. Sun Pharmaceutical Description and Business Overview
Table 65. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Sun Pharmaceutical Main Product
Table 67. Sun Pharmaceutical Recent Development
Table 68. Teva Corporation Information
Table 69. Teva Description and Business Overview
Table 70. Teva Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Teva Main Product
Table 72. Teva Recent Development
Table 73. Fresenius Kabi Corporation Information
Table 74. Fresenius Kabi Description and Business Overview
Table 75. Fresenius Kabi Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Fresenius Kabi Main Product
Table 77. Fresenius Kabi Recent Development
Table 78. Hospira(Pfizer) Corporation Information
Table 79. Hospira(Pfizer) Description and Business Overview
Table 80. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Hospira(Pfizer) Main Product
Table 82. Hospira(Pfizer) Recent Development
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Mylan Main Product
Table 87. Mylan Recent Development
Table 88. Taj Pharmaceuticals Corporation Information
Table 89. Taj Pharmaceuticals Description and Business Overview
Table 90. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Taj Pharmaceuticals Main Product
Table 92. Taj Pharmaceuticals Recent Development
Table 93. Jiangsu Hengrui Medicine Corporation Information
Table 94. Jiangsu Hengrui Medicine Description and Business Overview
Table 95. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Jiangsu Hengrui Medicine Main Product
Table 97. Jiangsu Hengrui Medicine Recent Development
Table 98. Nanjing Pharmaceutical Factory Corporation Information
Table 99. Nanjing Pharmaceutical Factory Description and Business Overview
Table 100. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Nanjing Pharmaceutical Factory Main Product
Table 102. Nanjing Pharmaceutical Factory Recent Development
Table 103. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 104. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 105. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Jiangsu Aosaikang Pharmaceutical Main Product
Table 107. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 108. Qilu Pharmaceutical Corporation Information
Table 109. Qilu Pharmaceutical Description and Business Overview
Table 110. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Qilu Pharmaceutical Main Product
Table 112. Qilu Pharmaceutical Recent Development
Table 113. Hisun Pharmaceutical Corporation Information
Table 114. Hisun Pharmaceutical Description and Business Overview
Table 115. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Hisun Pharmaceutical Main Product
Table 117. Hisun Pharmaceutical Recent Development
Table 118. Luoxin Corporation Information
Table 119. Luoxin Description and Business Overview
Table 120. Luoxin Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. Luoxin Main Product
Table 122. Luoxin Recent Development
Table 123. Lingnan Pharmacy Corporation Information
Table 124. Lingnan Pharmacy Description and Business Overview
Table 125. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 126. Lingnan Pharmacy Main Product
Table 127. Lingnan Pharmacy Recent Development
Table 128. Hansoh Pharma Corporation Information
Table 129. Hansoh Pharma Description and Business Overview
Table 130. Hansoh Pharma Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. Hansoh Pharma Main Product
Table 132. Hansoh Pharma Recent Development
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Platinum-based Anticancer Drugs Distributors List
Table 136. Platinum-based Anticancer Drugs Customers List
Table 137. Platinum-based Anticancer Drugs Market Trends
Table 138. Platinum-based Anticancer Drugs Opportunities and Drivers
Table 139. Platinum-based Anticancer Drugs Market Challenges
Table 140. Global Platinum-based Anticancer Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 141. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Type (2021-2026)
Table 142. Global Platinum-based Anticancer Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 143. Global Platinum-based Anticancer Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 144. Global Platinum-based Anticancer Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 145. Global Platinum-based Anticancer Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 146. Global Platinum-based Anticancer Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 147. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Region (2021-2026)
Table 148. Global Platinum-based Anticancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Platinum-based Anticancer Drugs
Figure 2. Global Platinum-based Anticancer Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Cisplatin Product Picture
Figure 4. Carboplatin Product Picture
Figure 5. Oxaliplatin Product Picture
Figure 6. Nedaplatin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Platinum-based Anticancer Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 9. Testicular Cancer
Figure 10. Osteosarcoma
Figure 11. Breast Cancer
Figure 12. Esophageal Cancer
Figure 13. NSCLC
Figure 14. Other
Figure 15. Global Platinum-based Anticancer Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Platinum-based Anticancer Drugs Sales Capacity (K Units) (2015-2026)
Figure 17. Global Platinum-based Anticancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Platinum-based Anticancer Drugs Sales Share by Manufacturers in 2020
Figure 19. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers in 2019
Figure 20. The Global 5 and 10 Largest Players: Market Share by Platinum-based Anticancer Drugs Revenue in 2019
Figure 21. Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2015-2020)
Figure 23. Global Platinum-based Anticancer Drugs Sales Market Share by Region in 2019
Figure 24. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2015-2020)
Figure 25. Global Platinum-based Anticancer Drugs Revenue Market Share by Region in 2019
Figure 26. North America Platinum-based Anticancer Drugs Sales Market Share by Country in 2019
Figure 27. North America Platinum-based Anticancer Drugs Revenue Market Share by Country in 2019
Figure 28. U.S. Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. U.S. Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Canada Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. Canada Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. Europe Platinum-based Anticancer Drugs Sales Market Share by Country in 2019
Figure 33. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country in 2019
Figure 34. Germany Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Germany Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. France Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. France Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. U.K. Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.K. Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Italy Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Italy Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Russia Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Russia Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Asia Pacific Platinum-based Anticancer Drugs Sales Market Share by Region in 2019
Figure 45. Asia Pacific Platinum-based Anticancer Drugs Revenue Market Share by Region in 2019
Figure 46. China Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. China Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Japan Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Japan Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. South Korea Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. South Korea Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. India Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. India Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Australia Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Australia Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Taiwan Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Taiwan Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Indonesia Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Indonesia Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Thailand Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Thailand Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Malaysia Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Malaysia Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Philippines Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Philippines Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Vietnam Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Vietnam Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Latin America Platinum-based Anticancer Drugs Sales Market Share by Country in 2019
Figure 69. Latin America Platinum-based Anticancer Drugs Revenue Market Share by Country in 2019
Figure 70. Mexico Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Mexico Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Brazil Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Brazil Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Argentina Platinum-based Anticancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Platinum-based Anticancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Middle East and Afr
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs